WWM
AXSM icon

Wolff Wiese Magana’s Axsome Therapeutics AXSM Stock Holding History

Wolff Wiese Magana’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.88K Hold
24
– – ﹤0.01% 604
2026
Q1 		$4.06K Hold
24
– – ﹤0.01% 645
2025
Q4 		$4.38K Buy
+24
New +$3.35K ﹤0.01% 610
2025
Q3 		– Sell
-10
Closed -$1.04K – 965
2025
Q2 		$1.04K Hold
10
– – ﹤0.01% 838
2025
Q1 		$1.17K Hold
10
– – ﹤0.01% 829
2024
Q4 		$847 Hold
10
– – ﹤0.01% 839
2024
Q3 		$899 Buy
+10
New +$873 ﹤0.01% 866

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
CA
Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Wolff Wiese Magana's AXSM Position: Q2 2026 in Review

Wolff Wiese Magana held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 24 shares worth $5.88K. The position accounts for ﹤0.01% of the portfolio, ranked #604.

Wolff Wiese Magana first reported a position in AXSM in Q3 2024 and has held it in 7 quarters since. 38 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Wolff Wiese Magana held 24 shares of Axsome Therapeutics worth $5.88K as of Q2 2026.
  • Wolff Wiese Magana left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #604 holding.
  • Wolff Wiese Magana first reported a position in Axsome Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 38 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.